International Foundation for Gastrointestinal Disorder

This trial is not actively recruiting.

This trial has completed recruitment on this platform, and is no longer accepting new referrals.

Feeling the drain of Major Depressive Disorder?

Learn more about a 14-week depression study where you may participate from home.

Trial ID: NCT04423757

Trial Details

An at-home, 14-week study for adults that explores whether an investigational study drug, taken daily, is effective in treating depression. Participants will use a smartphone app for visits with the study team and to complete daily eDiaries.

Estimated Enrollment

164 Participants

Phase

2

Eligibility Criteria

Participants must:
  • Have been diagnosed with major depressive disorder
  • Are 18–65 years old
  • Are currently taking an antidepressant
Participants must not:
  • Have bi-polar disorder or personality disorder (such as antisocial, paranoid, schizoid, or schizotypal)

This is a 14 week at home study where the participant must reside in one of the states below:

  • Alabama
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • District of Columbia
  • Florida
  • Georgia
  • Illinois
  • Indiana
  • Kentucky
  • Louisiana
  • Maryland
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Jersey
  • New York
  • North Carolina
  • Ohio
  • Oklahoma
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Utah
  • Virginia
  • Washington

Frequently Asked Questions (FAQs)